跳至主要内容
临床试验/NL-OMON47895
NL-OMON47895已完成3 期

Randomized Multicentre Phase III study of short course radiation therapy followed by prolonged pre-operative chemotherapy and surgery in primary high risk rectal cancer compared to standard chemoradiotherapy and surgery and optional adjuvant chemotherapy (RAPIDO study) - RAPIDO

niversitair Medisch Centrum Groningen0 个研究点目标入组 361 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
361

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Biopsy-proven, newly diagnosed primary rectal adenocarcinoma.
  • Locally advanced tumour fulfilling at least one of the following criteria on
  • pelvic MRI indicating high risk of failing locally and/or systemically:
  • o Clinical stage (c) T4a
  • o Positive MRF, i.e. tumour <= 1 mm from the mesorectal fascia
  • Staging done within 5 weeks before randomization.
  • Age >= 18 years.
  • ECOG Performance Status of 0 - 1.

排除标准

  • Extensive growth into cranial part of the sacrum (above S3) or the
  • lumbosacral nerve roots.
  • Metastatic disease or recurrent rectal tumour. Familial Adenomatosis
  • Polyposis coli (FAP), Hereditary Non-Polyposis Colorectal Cancer (HNPCC),
  • active Crohn*s disease or active ulcerative Colitis.
  • Pregnancy or lactation.

研究者

相似试验